We are live on
!
Find out more
SH
Svenska Handelsbanken Portfolio holdings
AUM
$1.38M
1-Year Est. Return
61.04%
This Fund
S&P 500
This Quarter
Est. Return
+8.69%
1 Year Est. Return
+61.04%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$991M
AUM Growth
–
Cap. Flow
+$999M
Cap. Flow
% of AUM
100.83%
Top 10 Holdings %
Top 10 Hldgs %
90.09%
Holding
68
New
68
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$154M |
| 2 |
Bank of America
BAC
|
+$143M |
| 3 |
Goldman Sachs
GS
|
+$133M |
| 4 |
Intel
INTC
|
+$101M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$99.6M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 28.89% |
| 2 | Healthcare | 24.78% |
| 3 | Technology | 14.97% |
| 4 | Energy | 6.38% |
| 5 | Communication Services | 6.25% |
Similar funds
CAM
HGCK
DF
DILIH
AMC
HB
SI
SCM
Svenska Handelsbanken's Q4 2015 Portfolio in Review
Q4 2015 is the first quarter with a 13F filing on record for Svenska Handelsbanken, which disclosed 68 positions worth $991M. Its ten largest holdings account for 90% of the portfolio.
Its largest position is Pfizer: 4,901,872 shares worth $150M.
By sector, the portfolio is most concentrated in Financials at 29% of assets, followed by Healthcare and Technology.
- Svenska Handelsbanken's largest Q4 2015 buy was Pfizer: 4,901,872 shares worth $150M.
- Svenska Handelsbanken's ten largest holdings make up 90% of its $991M portfolio in Q4 2015.
- Svenska Handelsbanken disclosed 68 positions in Q4 2015, its first 13F filing on record.
Based on Svenska Handelsbanken's 13F filing for Q4 2015, filed 16 Feb 2016.